The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Levetiracetam · LEVETIRACETAM 500 mg/5mL · Injection, Solution, Concentrate · Intravenous · Sagent Pharmaceuticals
NDC 25021-0780-05 · 10 VIAL in 1 CARTON / 5 mL in 1 VIAL · ANDA · View full market →
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| XGen Pharmaceuticals DJB, Inc. | LEVETIRACETAM 500 mg/5mL | Sep 3, 2026 | Sep 3, 2026 |
| Aryeh Pharma corp | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Corporation | LEVETIRACETAM 100 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Novadoz Pharmaceuticals LLC | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Precision Dose, Inc. | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| UCB, Inc. | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| TAGI Pharma, Inc. | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Aug 5, 2026 |
| Sagent Pharmaceuticals | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Levetiracetam — NDC 25021-0780-05," retrieved September 3, 2026, https://drugdashboards.com/drug/25021078005.
Free to cite with attribution — see how the data is put together.